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Prevalence and predictors of posttraumatic stress disorder in
patients with acute myocardial infarction
Abstract
OBJECTIVE: We estimated the prevalence of posttraumatic stress disorder (PTSD) and identified
predictors of self-rated PTSD symptoms in patients post-myocardial infarction (MI). METHODS: We
recruited 400 patients (mean age 60 +/- 12 years, 79% were men) with a previous acute index MI who
were referred to a tertiary cardiology clinic. PTSD was assessed by the Clinician-administered PTSD
Scale, and self-rated severity of PTSD symptom levels were assessed by the Posttraumatic Diagnostic
Scale. RESULTS: Of the 190 patients who completed the Posttraumatic Diagnostic Scale, 34 met the
cutoff for clinically significant PTSD symptomatology and 32 agreed to be interviewed. Among these
patients, the Clinician-administered PTSD Scale interview yielded a prevalence of full and
subsyndromal PTSD of 9.5% (95% confidence interval 7.4-11.6). Retrospectively rated feelings of
helplessness (beta = .47, P < .001) and pain intensity during MI (beta = .15, P = .019) independently
predicted PTSD symptom level. CONCLUSIONS: Approximately 10% of patients post-MI had full or
subsyndromal PTSD. Subjective perception of MI predicted self-rated PTSD symptom level.
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ABSTRACT 
Objective: We estimated the prevalence of Posttraumatic Stress Disorder (PTSD) and 
identified predictors of self-rated PTSD symptoms in post-myocardial (MI) patients. 
 
Methods: We recruited 400 patients (mean age 60±12 years, 79% men) with a 
previous acute index MI referred to a tertiary cardiology clinic. PTSD was assessed by the 
Clinician-administered PTSD Scale (CAPS) and self-rated severity of PTSD symptom levels 
by the Posttraumatic Diagnostic Scale (PDS).  
 
Results: Of the 190 patients who completed the PDS, 34 met the cut-off for clinically 
significant PTSD symptomatology and 32 agreed to be interviewed. In these, the CAPS 
interview yielded a prevalence of full and subsyndromal PTSD of 9.5% (95% CI 7.4-11.6). 
Retrospectively rated feelings of helplessness (β=.47, p<.001) and pain intensity during MI 
(β=.15, p=.019) independently predicted PTSD symptom level.  
 
Conclusions: Almost 10% of post-MI patients had full or subsyndromal PTSD. 












Patients commonly perceive a heart attack as a vital threat to their life inflicting 
feelings of fear, loss of control, and helplessness.1,2 This intense psychological distress may 
extend the acute phase of a myocardial infarction (MI) in a number of patients.3 Two recent 
reviews found that, on average, 15% of patients develop posttraumatic stress disorder (PTSD) 
post-MI.4,5 To meet the diagnostic criteria for PTSD according to the fourth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV),6 the patient must have 
experienced the MI as an event involving threatened death (criterion A1) to which he or she 
responded with intense fear, helplessness, or horror (criterion A2). Three characteristic 
symptom clusters related to reexperiencing the MI (criterion B), avoidance of stimuli 
associated with the MI (criterion C), and hyperarousal (criterion D) must have persisted for at 
least one month (criterion E) and have caused clinically significant distress or impairment in 
daily functioning.  
In addition to increased psychological distress,7 reduced quality of life, and impaired 
social functioning,8 PTSD may prospectively increase cardiovascular morbidity in MI 
patients9 and overall cardiovascular mortality.10 Some of the cardiovascular risk of PTSD may 
relate to poor adherence to cardiac medication,9,11 and to the clustering of established 
cardiovascular risk factors12-15 and poor life style habits16, 17 in these patients. 
Pathophysiological evidence exists for a systemic low-grade proinflammatory and 
procoagulant state and a sympathovagal imbalance in PTSD, all of which could contribute to 
atherosclerosis and complicate acute coronary syndromes.5, 18 Therefore, a considerable 
proportion of post-MI patients might benefit from screening for and treatment of PTSD.  
Previous estimates of prevalence of PTSD in post-MI patients are limited by studies 
with comparatively small samples and the heterogeneity of tools applied to diagnose PTSD.5 
In fact, only three studies on 52 or fewer patients have performed a clinical interview to 
diagnose PTSD related to MI.19-21 Importantly, these investigations yielded lower prevalence 
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rates of PTSD (i.e. 0-8%) than those inferred from studies using self-report questionnaires 
asking into PTSD symptoms.5 Moreover, the Clinician-administered PTSD Scale (CAPS) 
diagnostic interview to diagnose PTSD according to DSM-IV criteria22 was not used in any of 
these previous studies. Before resources are allocated in clinical trials addressing PTSD in MI 
patients, there is an urgent need for larger studies administering sound diagnostic procedures 
to estimate the frequency of PTSD post-MI.4 
Our primary aim and the novel aspect of this study was therefore to determine the 
prevalence of PTSD applying the CAPS diagnostic interview in a sizeable sample of 
consecutive patients who had experienced an acute MI. Based on previous research 19-21, we 
hypothesized that applying a structured interview in a reasonably large sample would yield a 
prevalence of about 10% of post-MI patients having PTSD. Research suggests that subjective 
perception of a heart attack is more important in predicting PTSD symptom severity than 
objective measures of MI severity such as levels of creatine kinase (CK) and duration of 
hospitalization.23 Patients’ retrospective ratings of higher awareness of having MI at the time 
of symptoms24 and of lower degree of control during MI,21 as well as prospective ratings of 
more perceived threat immediately after MI23 and of pain intensity during MI25 predicted 
higher levels of PTSD symptoms. Therefore, our secondary aim was to retrospectively 
identify subjective predictors of self-rated PTSD symptom level related to MI, namely fear of 
dying, feelings of helplessness, and pain intensity perceived during MI. We hypothesized that 
these subjective measures of perceived distress would have a comparably stronger predictive 
value for PTSD symptom level than objective measures of MI severity. 
 
METHODS 
Study design and participants  
The Ethics Committee of the State of Berne, Switzerland, formally approved the study 
protocol and all participants provided informed consent. All patients were recruited between 
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January and December 2005 from the Cardiology Department of the University Hospital of 
Berne. After having verified the diagnosis of an acute MI from medical records, we contacted 
eligible patients by mail. We approached a consecutive sample of 400 patients with a previous 
acute index MI (i.e. first-time MI or most recent MI in patients with recurrent MI). A power 
analysis justifying this sample size was made based on the following assumptions. The 
weighted prevalence of PTSD across three previous smaller studies was 6% when the 
diagnosis was made by a clinical interview.5 In line with a recent study, we assumed that 
about half of the 400 eligible patients approached would not respond to our PTSD survey 
because of avoidance behavior and other reasons.26 Therefore, the statistical power to detect 
our initially hypothesized 10% prevalence of PTSD in a sample of 200 post-MI patients we 
assumed would eventually participate was 72% at an alpha error of 5%. 
Acute MI was defined as per a typical rise and fall of biochemical markers of 
myocardial necrosis (twice the upper norm level in CK-MB (>380 U/L) or in troponin (>0.4 
μg/L)) with at least one of the following: (a) ischemic symptoms; (b) development of 
pathologic Q waves on the electrocardiogram (ECG); (c) ECG changes indicative of ischemia 
(ST segment elevation or depression); or (d) coronary artery intervention (e.g., coronary 
angioplasty)27. Patients were excluded if they did not speak German or lived too far away 
from the University Hospital (>90 minutes by car or train). As an incentive, participants were 
offered counselling for their traumatic experience, which included referral to a psychologist 
trained in trauma therapy. 
 
Psychometric assessment 
The Posttraumatic Diagnostic Scale (PDS)28 was mailed home to all 400 patients with 
an index MI. The PDS is a self-report measure consisting of 17 questions mapping onto 
DSM-IV symptoms for PTSD. In the questionnaire we replaced the term “event” with the 
term “heart attack”.24 Patients rated on a 4-point scale how often they had experienced each 
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symptom during the past month (0=not at all, 3=often). We applied the validated German 
version of the PDS29 showing excellent internal consistency (Cronbach’s α = .91) (Steil, 
unpublished manuscript). The PDS performs well as a screening tool to identify clinical cases 
of PTSD.30 Patients who met the cut-off for mild PTSD symptom level (≥15 PDS points)31 
were invited for the CAPS interview. 
When completing the PDS, patients also rated three aspects of subjective perception of 
MI severity on a Likert scale: a) fear of dying: “During my referral to the hospital, the 
emergency unit, or the intensive care unit, I was afraid I was dying.” (0 = absolutely not true, 
10 = absolutely true); b) helplessness: “When the doctor told me I had a heart attack, I was 
frightened, felt helpless, and was afraid of losing control of the situation.” (0 = absolutely not 
true, 10 = absolutely true); c) pain intensity: “Please indicate how strong your pain was during 
the heart attack.” (0 = no pain at all, 10 = intolerable pain). 
We selected the CAPS for the structured interview because this instrument has been 
developed by the National Center for PTSD to diagnose current and lifetime PTSD as defined 
in DSM-IV.22 This instrument allows quantification of the frequency and intensity of each of 
the 17 PTSD symptoms according to the DSM-IV. A diagnosis of PTSD can also be made 
based on the CAPS. The German version of the CAPS shows good internal consistency for 
the severity score of all 17 items (Cronbach’s α =.88-.92) and for each of the three PTSD 
symptom clusters (α =.73-.88).32 The frequency and intensity of each symptom is rated on a 
5-point scale ranging between e.g. “never” (0 points) to “almost always” (4 points). A 
particular symptom is regarded as present when rated with a frequency of ≥1 point and an 
intensity of ≥2 points. According to the DSM-IV, to meet diagnostic criteria for a particular 
symptom cluster, 1 of 5 symptoms must be given for criterion B (re-experiencing), 3 of 7 
symptoms for criterion C (avoidance), and 2 of 5 symptoms for criterion D (hyperarousal), 
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respectively. Overall severity of diagnostic PTSD is obtained by adding up symptom scores of 
criteria B+C+D.  
We estimated the prevalence of PTSD in two different ways depending on whether the 
criterion A2 (i.e. subjective response of intense fear, helplessness, or horror to the MI) was 
affirmed or not. This distinction might be important because the DSM-IV explicit requirement 
that only traumatic events meeting the two-part definition (A1 and A2) qualify as PTSD-level 
stressors might be a source of bias in that e.g. women may report more A2 symptoms than 
men.33 Patients were diagnosed with subsyndromal PTSD if they met criterion A and criterion 
B (re-experiencing cluster) plus either criterion C (avoidance cluster) or criterion D 
(hyperarousal cluster).34 
 
Sociodemographic and biological data 
Age, gender, date of index MI, type of MI (first-time vs. recurrent MI), left ventricular 
ejection fraction (LVEF) as measured by ventriculography during coronary angiography, and 
proxy measures of infarct size (serum levels of total CK and troponin-I) were all obtained 
from medical charts. Biochemical markers of myocardial necrosis were measured by different 
laboratories and were, therefore, not standardized. Nevertheless, left ventricular function as 
determined by LVEF has prognostic value in post-MI patients.27 Determination of the time 
courses of CK- and troponin-levels during the acute phase of the MI did not follow a 
standardized protocol; therefore, “highest” levels of total CK and troponin-I do not 
necessarily reflect “peak” levels.  
 
Statistical analyses 
Data analysis used SPSS 13.0 statistical software package (SPSS Inc. Chicago, IL). 
All tests were two-tailed with significance level set at p<.05. Values of PDS and Likert scale 
scores, number of days after MI the PDS was sent out, levels of CK and troponin, and LVEF 
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showed no normal distribution (Kolmogorov-Smirnov Test) and were transformed by the 
Blom procedure before statistical analyses. For clarity, we present all data in original units 
(means±SD with range). Differences between two grouping variables were calculated using 
Student’s t-test, Pearson chi-square test, and Fisher’s exact test where appropriate. Pearson 
correlations quantified the bivariate relationship between continuous variables. Multiple linear 
regression analysis was calculated using the enter method to identify predictors of PTSD 




Patient characteristics  
Of the 400 MI patients approached, 204 PDS questionnaires were returned (51%), 
which had been sent out after a median of 40 days (range 12 days – 4.5 years) after the index 
MI. Six patients had died and their relatives returned the questionnaire. Eight patients 
returned the questionnaire but declined to complete it. Screening for PTSD symptomatology 
was therefore performed in 190 MI patients (48%). These patients were not significantly 
different in age from the 196 patients who did not respond to the survey (p=.60). However, 
the proportion of women was significantly higher in patients who did not return the 
questionnaire than among those who completed it (13% vs. 8%, p=.025).  
Table 1 shows demographic, diagnostic and psychological characteristics of 190 MI 
patients screened for PTSD. One and two PDS items were missing in six and in one patient, 
respectively, and were replaced by the mean of completed items. Likert scores for fear of 
dying, helplessness, and pain intensity were missing in five, four, and three cases, 
respectively. Levels of CK and troponin could not be obtained in 38 and 55 cases, 
respectively. We therefore used LVEF (missing in eight patients) as an objective proxy 
measure of MI severity and used CK and troponin values only for complementary analyses.  
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Prevalence of PTSD diagnosis 
Thirty-four patients (17.9%; 95% CI 15.2-20.6) had a PDS score ≥15 meeting the cut-
off for the diagnostic interview for PTSD. Two female patients with a PDS score of 15 and 19 
points, respectively, declined to participate in the CAPS interview. The patient sample 
undergoing the diagnostic interview included 24 men and 8 women with a mean age of 54±9 
years who had experienced first-time MI in 27 cases and recurrent MI in 5 cases, respectively 
(p=1.00 for type of MI). On average, patients were interviewed 95±68 days (range 24-336) 
post-MI. One patient was interviewed 24 days post-MI (i.e. within less than one month of the 
trauma) but did not meet criteria for either full or subsyndromal PTSD. Mean PTSD severity 
score obtained by the CAPS was 45±27 (range 9-119) and, as expected, correlated highly with 
the PDS score (r=.81, p<.001) but not significantly so with time since MI. Average scores for 
fear of dying were 6.2± 3.2, for feelings of helplessness 6.7±3.1, and for pain intensity 
7.2±2.5. Table 2 shows that the PTSD patients were of younger age, and, as expected, had 
also higher scores of posttraumatic symptoms, fear of dying, helplessness, and pain relative to 
patients without PTSD. The proportion of gender and type of infarction, as well as objective 
measures of MI severity, were not significantly different between patients with PTSD and 
those without. 
Table 3 shows the prevalences of full PTSD and subsyndromal PTSD according to 
different definitions of the DSM-IV criterion A.31 A total of 9.5 % (95% CI 7.4-11.6) of 
patients were diagnosed with either full or subsyndromal PTSD if criterion A2 was not taken 
into account for the diagnosis. When an affirmative response for the A2 criterion was 
explicitly required, all nine subjects with a full PTSD (4.7%; 95% CI 3.2-6.2) maintained 
their diagnosis, but the prevalence of subsyndromal PTSD dropped slightly from 4.7% (95% 




Predictors of self-rated PTSD symptom level 
In bivariate analyses, PDS score correlated with age (r=-.19, p=.010, Fig. 1, Panel A), 
fear of dying (r=.56, p<.001; Fig. 1, Panel B), helplessness (r=.64, p<.001; Fig. 1, Panel C), 
and pain intensity (r=.31, p<.001; Fig. 1, Panel D). In contrast, there were no significant 
associations between PDS score and gender, type of MI, time after MI PDS was sent out, 
LVEF, and highest CK and troponin levels. We then regressed age, gender, type of MI, time 
after MI the PDS was sent out, the three Likert scale scores (fear of dying, helplessness, pain), 
and LVEF in one block on PDS scores. Helplessness (standardized β-coefficient =.47, t=4.86, 
p<.001) and pain intensity (β=.15, t=2.37, p=.019) were independent predictors of self-rated 
PTSD symptom levels. In addition, female gender reached borderline significance as a 
predictor of PTSD symptom level (β=.11, t=1.80, p=.074). Results did not substantially 
change when highest levels of CK and troponin were also entered into the regression 
equation. Levels of CK and troponin did not significantly predict PTSD symptom level. 
 
DISCUSSION 
We applied the CAPS structured interview in the hitherto largest study investigating 
the prevalence of a DSM-IV PTSD diagnosis in a sample of patients with a previous MI. We 
found that almost 10% of post-MI patients had full or subsyndromal PTSD. This diagnosis 
posits that patients experienced their MI as an intense threat to their life to which they 
responded emotionally with intense fear, helplessness, or horror. For at least one month, these 
patients re-experienced aspects of the MI (e.g. intrusive thoughts or nightmares), avoided 
stimuli related to the MI (e.g. intake of cardiac medication), and had symptoms of increased 
arousal (e.g. sleep disturbances and irritability). The combined prevalence of full and 
subsyndromal PTSD was similar to PTSD prevalence (7-8%) found in two previous studies 
using an interview on 27 and 52 post-MI patients, respectively,20, 21 but higher than in a small 
study on 23 patients of whom none was diagnosed with full PTSD.19 This prevalence of 
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clinical PTSD post-MI is noteworthy given that 12-month prevalence of subsyndromal PTSD 
was <2% and no individual met criteria for full PTSD in a representative Swiss population 
sample.35 A comparatively high PTSD prevalence as in our post-MI patients was found in 
Swiss accident victims one year after referral to the intensive care unit where 1.9% had full 
PTSD and 12.3% had subsyndromal PTSD.34 Notably, PTSD diagnosis was not associated 
with time since MI, suggesting and corroborating review data5 that post-MI PTSD does not 
readily wane over time. 
Previous studies did not clinically assess subsyndromal PTSD19-21 now acknowledged 
as a specific nosological subcategory of PTSD.36 In a clinical setting, patients with 
subsyndromal PTSD should not be overlooked because they endorse marked levels of 
psychological distress and low functional status.37 The distinction between patients who 
affirmed the A2 criterion in the interview (i.e. negative emotional response to MI) and those 
who did not had no influence on the prevalence of full PTSD. The prevalence of 
subsyndromal PTSD decreased only slightly if the A2 criterion was requested. This suggests 
that in post-MI patients with clinical PTSD the traumatic event of experiencing an acute MI 
regularly evoked intense emotional distress. Or, in other words, if patients did not perceive 
emotional distress at the time of MI, the odds for not developing PTSD were substantially 
higher. This notion is in line with a large community-based study showing that traumatic 
events not involving symptoms of the A2 criterion rarely resulted in PTSD.33 
Parsimoniously interpreted, subjective perception of MI was more important than 
demographic variables and LVEF, a proxy measure of objective MI severity, in predicting 
self-rated PTSD symptom level. Higher levels of all three measures of subjectively perceived 
distress (i.e. fear of dying, helplessness, and pain) correlated with higher levels of PTSD 
symptom levels in bivariate analyses with helplessness and pain intensity emerging as 
independent predictors of PDS scores. These findings are in line with other studies showing 
that posttraumatic stress, along a continuum of severity, related to aspects of subjective 
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appraisal of the MI as a traumatic event21,23-25 but not to objective severity of MI.23 We 
propose that decreasing feelings of helplessness and improving pain control during MI could 
be reasonable means to possibly decrease clinically significant PTSD symptom level and 
perhaps the development of diagnostic PTSD in the aftermath of an acute MI. Female gender 
showed borderline significance as an independent predictor of relatively higher PTSD 
symptom level in accordance with the observation that women with PTSD endorse more A2 
symptoms (e.g. helplessness) than men.33 
Besides lacking a control group, we address several limitations of our study. First, 
prevalence of diagnostic PTSD and self-rated PTSD symptom level may not necessarily 
transfer to a general population of post-MI patients. Only 48% of patients contacted by mail 
were available for PTSD screening and women were underrepresented in patients who 
consented to the screening procedure. On average, women experience more emotional distress 
with PTSD than do men.33 Why did half of contacted patients not respond to our survey? 
Female MI patients, but also patients with high avoidance scores in general, might feel 
comparatively reluctant to take part in a survey asking into traumatic MI experiences in order 
to avoid reminders of their heart attack.24 If this is the case, the “true” prevalence of PTSD in 
a general population of post-MI patients would be even higher than here observed. For 
instance, if we assume that in the non-responding subjects the prevalence of PTSD was twice 
as high (19%) as in the sample we could screen for PTSD (9.5%), then the prevalence of 
PTSD in the entire study population of 400 patients would have been 14.5 % (95% CI 12.3-
16.7). Consequently, a considerable number of PTSD patients would go undiagnosed since 
they were not reached by the screening questionnaire. Future studies may want to address the 
question whether with a recruitment strategy that is more specifically tailored to increase 
accrual rate among post-MI patients with high posttraumatic symptom levels the prevalence 
rate of PTSD would be different from that observed in our study.  
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Second, to rule out recall bias, and to corroborate the importance of subjective MI 
perception in predicting PTSD symptom level, future studies should assess emotional distress 
prospectively and along with standardized assessment of biochemical markers of myocardial 
necrosis (i.e. peak levels of CK-MB) and more precise measurements of left ventricular wall 
motion abnormalities or ST-elevation findings on ECG.27 Third, like the bulk of previous 
studies on PTSD in post-MI patients,5 we did not control for depression, which shows high 
comorbidity with PTSD38 and is prevalent in post-MI patients.39 For instance, sleep problems 
and irritability of the PTSD hyperarousal symptom cluster are also characteristic of 
depression. As most recently shown, approximately half of major depressive episodes are 
already present prior to MI.40  Depression is associated with both increased reporting of chest 
pain by cardiac and non-cardiac patients41 and feelings of helplessness.42 Helplessness and 
pain intensity during MI could therefore mediate some of the effect of depression on PTSD 
symptom level. In turn, depression immediately following MI onset is often reactive40 raising 
the question to what extent PTSD symptoms account for depressive adjustment disorder 
following MI. Fourth, although the questions of the CAPS interview were tailored to ask for 
PTSD symptoms specifically related to MI, we did not ask for other potential sources of 
PTSD symptoms such as related to the intensive care unit treatment, invasive procedures 
performed, cardiac arrest, resuscitation, and a history of trauma. Fifth, we did not consider the 
use of beta-blocking agents, selective serotonin reuptake inhibitors, and benzodiazepines 
around the acute phase of MI or thereafter. Therefore, we are unable to state whether in some 
patients such drugs mitigated manifestation of PTSD.43 
We conclude that the prevalence of PTSD in post-MI patients is of clinical relevance 
and that patients’ subjective perception of their MI substantially predicts PTSD symptom 
level all of which may have important clinical implications. There is substantial impairment in 
daily functioning and health care consumption in patients with PTSD.37,44 Moreover, first 
evidence suggests that PTSD symptom level prospectively predicts cardiovascular events in 
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subjects initially free of coronary artery disease45 and in post-MI patients.9 We therefore 
would like to encourage clinicians to regularly evaluate post-MI patients in terms of PTSD 
symptoms related to acute MI. Although specific interventions for post-MI patients suffering 
of PTSD are only beginning to emerge,46 there are established treatments available for PTSD 
due to other sources, broadly referring to counseling, cognitive-behavioral and interpersonal 
psychotherapy, and psychopharmacology.43,44 However, in a busy cardiology setting, 
clinicians may also want to test whether an undemanding intervention aimed at reducing 
emotional distress (e.g. leaflet information, short-term cognitive restructuring, and pain 
control) in the acute phase of MI can prospectively reduce PTSD symptomatology and the 
risk of developing diagnostic PTSD post-MI, respectively. 
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Legend to Figure 1 
Panels A-D depict the significant bivariate correlations between the Posttraumatic 
Diagnostic Scale (PDS) score (“stress score”) and age (A), perceived fear of dying (B), 
























Table 1. Characteristics of 190 patients screened for PTSD 
  
Men / Women [%] 165 (84%) / 33 (16%) 
Age [years] 60 ± 12 (38-85) 
First-time / recurrent infarction [%] 177 (89%) / 21 (11%) 
Highest serum total creatinine kinase level obtained [U/L] 1244 ± 1313 (65-6339) 
Highest serum troponin-I level obtained [μg/L] 129 ± 277 (0.2-2436) 
Left ventricular ejection fraction [%] 50 ± 11 (20-70) 
Posttraumatic diagnostic scale score 8.5 ± 9.1 (0-48) 
Fear of dying score 2.6 ± 3.2 (0-10) 
Feelings of helplessness score 3.0 ± 3.3 (0-10) 
Perceived pain score 5.7 ± 3.0 (0-10) 
 
Data are given as means ± SD (range) 
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Table 2. Differences in characteristics between patients with and without PTSD 
    
Variable Patients with PTSD 
(n=18) 
Patients without PTSD 
(n=172) 
P-value 
Men / Women [%] 15 (83%) / 3 (17%) 145 (84%) / 27 (16%) 1.000 
Age [years] 50 ± 8 (39-65) 61 ± 11 (38-85) <0.001 
First-time / recurrent 
infarction [%] 
16 (89%) / 2 (11%) 154 (90%) / 18 (10%) 1.000 
Highest serum total creatinine 
kinase level obtained [U/L] 
1447 ± 1687 (78-6339) 1222 ± 1271 (65-5880) 0.608 
Highest serum troponin-I level 
obtained [μg/L] 
98 ± 153 (0.2-560) 133 ± 288 (0.2-2436) 0.869 
Left ventricular ejection 
fraction [%] 
53 ± 10 (25-65) 50 ± 11 (20-70) 0.333 
Posttraumatic diagnostic scale 
score 
28.9 ± 9.9 (15-48) 6.3 ± 5.7 (0-22) <0.001 
Fear of dying score 7.8 ± 2.6 (3-10) 2.1 ± 2.7 (0-10) <0.001 
Feelings of helplessness score 8.1 ± 2.3 (3-10) 2.4 ± 2.9 (0-10) <0.001 
Perceived pain score 7.7 ± 2.2 (4-10) 5.5 ± 3.0 (0-10) 0.002 
 







Table 3. Diagnosis of full and subsyndromal PTSD in 32 patients interviewed 
   
CAPS Diagnosis Criterion A2 not required Criterion A2 required 
   
Full PTSD n=9 (4.7%; 95% CI 3.2-6.2) N=9 (4.7%; 95% CI 3.2-6.2) 
Subsyndromal PTSD n=9 (4.7%; 95% CI 3.2-6.2) N=6 (3.2%; 95% CI 1.9-4.5) 
No PTSD n=14 (7.4%; 95% CI 5.5-9.3) N=17 (8.9%; 95% CI 6.9-10.9) 
 
CAPS, clinician-administered PTSD Scale; PTSD, posttraumatic stress disorder 
Percent values of prevalence estimates with 95% confidence intervals refer to the total sample 
of patients who completed the Posttraumatic Diagnostic Scale (n=190)
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Panel B. Fear and stress score































Panel C. Helplessness and stress score
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